Literature DB >> 17713752

[Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].

K Ruprecht1.   

Abstract

Data from studies of twins and migrants with multiple sclerosis (MS) imply environmental factors in the development of MS. In this respect, increasing evidence indicates that Epstein-Barr virus (EBV) plays a unique role as an infectious risk factor for MS. A nearly 100% seroprevalence of antibodies to EBV in patients with MS, elevated EBV antibody titers years before clinical onset of the disease, and an increased risk for MS after symptomatic primary EBV infection (infectious mononucleosis) suggest an association of MS with a previous infection with EBV. However, the precise mechanisms through which EBV may contribute to MS are still unclear. Currently discussed potential mechanisms are outlined. The notion of a persisting (possibly immunological) change caused during the acute phase of primary EBV infection and subsequently leading to permanently elevated MS risk appears compatible with several aspects of the association found between MS and EBV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17713752     DOI: 10.1007/s00115-007-2335-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  Epstein-barr virus and risk of multiple sclerosis.

Authors:  Richard B Tenser
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

2.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

Authors:  Kassandra L Munger; Lynn I Levin; Bruce W Hollis; Noel S Howard; Alberto Ascherio
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

Review 3.  Viruses and multiple sclerosis.

Authors:  A G Dalgleish
Journal:  Acta Neurol Scand Suppl       Date:  1997

4.  Multiple sclerosis after infectious mononucleosis.

Authors:  Trine Rasmussen Nielsen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Sven Haahr; Per Soelberg Sørensen; Henrik Hjalgrim
Journal:  Arch Neurol       Date:  2007-01

5.  Epstein-Barr virus antibodies in multiple sclerosis.

Authors:  C V Sumaya; L W Myers; G W Ellison
Journal:  Arch Neurol       Date:  1980-02

6.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

7.  Epstein-Barr virus in pediatric multiple sclerosis.

Authors:  Suad Alotaibi; Julia Kennedy; Raymond Tellier; Derek Stephens; Brenda Banwell
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

8.  EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis.

Authors:  A C van Sechel; J J Bajramovic; M J van Stipdonk; C Persoon-Deen; S B Geutskens; J M van Noort
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.

Authors:  P Sundström; P Juto; G Wadell; G Hallmans; A Svenningsson; L Nyström; J Dillner; L Forsgren
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

10.  EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15.

Authors:  Delphine Sauce; Martin Larsen; S John Curnow; Alison M Leese; Paul A H Moss; Andrew D Hislop; Michael Salmon; Alan B Rickinson
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

View more
  3 in total

1.  Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections.

Authors:  Vladeta Ajdacic-Gross; Aleksandra Aleksandrowicz; Stephanie Rodgers; Mario Müller; Wolfram Kawohl; Wulf Rössler; Enrique Castelao; Caroline Vandeleur; Roland von Känel; Margot Mutsch; Roselind Lieb; Martin Preisig
Journal:  Front Psychiatry       Date:  2016-12-27       Impact factor: 4.157

2.  Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Authors:  René M Gieß; Catherina Pfuhl; Janina R Behrens; Ludwig Rasche; Erik Freitag; Nima Khalighy; Carolin Otto; Jens Wuerfel; Alexander U Brandt; Jörg Hofmann; Bettina Eberspächer; Judith Bellmann-Strobl; Friedemann Paul; Klemens Ruprecht
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

3.  Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.

Authors:  Hamidreza Honarmand; Masoumeh Ahmadi Jalali Moghadam; Hamidreza Hatamian; Ali Roudbary
Journal:  Jundishapur J Microbiol       Date:  2015-06-27       Impact factor: 0.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.